# SILODOSIN
> **ANDA209029** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2022-01-04
## Drug
- **FDA Application Number:** ANDA209029
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SILODOSIN
- **Generic name:** Silodosin
- **Active ingredients:** SILODOSIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PRINSTON INC
- **First approval:** 2022-01-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209029)
---
*AI Analytics · CC0 1.0*